Purple Biotech (PPBT) Net Income towards Common Stockholders (2014 - 2026)
Purple Biotech (PPBT) recorded Net Income towards Common Stockholders of -$441,000 in Q2 2026, compared with $1.09 million a year earlier.
Powered by 
Analysis
Purple Biotech (PPBT) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends
On a TTM basis, Purple Biotech's Net Income towards Common Stockholders came in at $24.49 million as of Jun 30, 2026, up 838.1% year-over-year; for FY2025, it came in at $26.49 million, up 264.0% from FY2024.
- Annual Net Income towards Common Stockholders has a five-year compound annual growth rate of -1.2% (FY2020 to FY2025).
- Across earlier years, Net Income towards Common Stockholders came in at $7.28 million in FY2024 (-63.6%), $19.98 million in FY2023 (-8.2%), $21.76 million in FY2022 (+17.8%) and $18.47 million in FY2021 (-34.2%).
- The Q2 2026 figure is the lowest quarterly Net Income towards Common Stockholders in data going back to Q3 2014.
- On a year-over-year basis, Net Income towards Common Stockholders rose in 1 of the last six quarters, with an average decline of 50.9%.
- Peak year-over-year performance for Net Income towards Common Stockholders in the last five years was growth of 96.5% in Q3 2025, against a decline of 91.5% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $86,000 (Q1 2026), $23.55 million (Q4 2025) and $1.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Purple Biotech | 247,575.07 | 189,575.07 | - | -441,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -441,000.00 |
| Mar 31, 2026 | 86,000.00 |
| Dec 31, 2025 | 23.55 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | 453,000.00 |
| Dec 31, 2024 | 410,000.00 |
| Sep 30, 2024 | 663,000.00 |
| Jun 30, 2024 | 2.41 Mn |
| Mar 31, 2024 | 3.76 Mn |
| Dec 31, 2023 | 4.83 Mn |
| Sep 30, 2023 | 5.04 Mn |
| Jun 30, 2023 | 5.14 Mn |
| Mar 31, 2023 | 4.88 Mn |
| Dec 31, 2022 | 6.01 Mn |
| Sep 30, 2022 | 4.82 Mn |
| Jun 30, 2022 | 3.54 Mn |
| Mar 31, 2022 | 7.30 Mn |
| Dec 31, 2021 | 5.11 Mn |
| Sep 30, 2021 | 3.15 Mn |
API Access
Purple Biotech Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=PPBT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "PPBT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=PPBT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();